Thanks Chris…. We are edging towards plaque-specific medical therapies?
View quoted post on X
curzen
@ncurzen
Professor of Interventional Cardiology in Southampton UK Expressed views are mine alone & do not represent any organisation
2.2K Following 5K Followers 5.7K Posts
Latest posts 5
These were patients with symptoms & moderate AS… a highly select group?
Should we not call moderate aortic stenosis anymore moderate?need to go through the paper yet..any thoughts?View quoted post on X
Important confirmation that the DOAC alone strategy is safe in stent patients with AF … after the standard period of DAPT
Presented at #TCT2026:
In patients with atrial fibrillation and a stent placed at least 1 year earlier, non–vitamin K antagonist oral anticoagulant monotherapy resulted in fewer net adverse clinical events at 2 years than a NOAC plus clopidogrel. Full ADAPT AF-DES trial results: nej.md/4yOOTgK
@crfheartView quoted post on X
Potentially important observation about diffuse disease & dcb
In an international cohort of 230 pts undergoing DCB-PCI for de novo #CAD, baseline physiological pattern influenced procedural results.
➡️ Diffuse vs focal disease showed smaller acute μFR gain & more suboptimal post-PCI physiology.
#JACCAsia #PCI
bit.ly/4eAarq4View quoted post on X
Can we improve outcomes for patients with acute myocardial infarction cardiogenic shock? Consensus thoughts from the BCIS Focus Group… #bcis
📚 New #ICRJournal Article: "Cardiogenic Shock Centres"
📚 Just Published!
🔓Access it here 👉 ow.ly/NchE106HrmF
@ncurzenView quoted post on X
